(lp0
S'Bio-Techne Corp  Moves Higher on Volume Spike for March 15 Equities.com - 12 hours ago Bio-Techne Corp  traded on unusually high volume on Mar. 15, as the stock gained 0.63% to close at $107.50. On the day, Bio-Techne Corp saw 404,531 shares trade hands on 2,699 trades. Considering that the stock averages only a daily volume of&nbsp;...BIO-TECHNE Corp  Lifted to Hold at Zacks Investment Research - Chaffey BreezeLarge Buying Action and Inflow of Money Witnessed in Bio-Techne Corp  - Highland Mirror'
p1
aS'Bio-Techne Corp  Ex-Dividend Date Scheduled for February 15, 2017 Nasdaq - Feb 14, 2017 Bio-Techne Corp  will begin trading ex-dividend on February 15, 2017. A cash dividend payment of $0.32 per share is scheduled to be paid on March 03, 2017.Bio-Techne Corp  to Issue Quarterly Dividend of $0.32 on March 3rd - Sports PerspectivesBio-Techne Corp  Consolidated Diluted EPS At 2.799 - Equities Focus'
p2
aS'Bio-Techne Corporation Completed its Acquisition of Advanced Cell Diagnostics PR Newswire  - Aug 1, 2016 MINNEAPOLIS, Aug. 1, 2016 /PRNewswire/ -- Bio-Techne Corporation  today announced it has completed its acquisition of Advanced Cell Diagnostics of Newark, CA.'
p3
aS'BRIEF-Bio-Techne Corp &amp; Bio-Techne has entered into an exclusive license agreement Reuters - Mar 7, 2017 BRIEF-Bio-Techne Corp &amp; Bio-Techne has entered into an exclusive license agreement. March 7 Bio-techne Corp: * Bio-Techne Corp - Bio-Techne has entered into an exclusive license agreement with multiclonal therapeutics. * Bio-Techne Corp - agreement&nbsp;...'
p4
aS'The BIO-TECHNE Corp  Lifted to Hold at Zacks Investment Research Petro Global News 24 - Mar 13, 2017 BIO-TECHNE Corp  was upgraded by Zacks Investment Research from a sell rating to a hold rating in a research note issued on Friday.Bio-Techne Corp  EPS Estimate At $0.88 - Markets DailyZacks Investment Research Upgrades BIO-TECHNE Corp  to Hold - The Cerbat Gem'
p5
aS'Bio-Techne Corporation Agrees to Acquire Zephyrus Biosciences, Inc. PR Newswire  - Mar 21, 2016 MINNEAPOLIS, March 21, 2016 /PRNewswire/ -- Bio-Techne Corporation  announced today that it has completed the acquisition of Zephyrus Biosciences.'
p6
aS'Staying Cautious On Bio-Techne For Now Seeking Alpha - Jul 17, 2016 The companys diversification strategy has provided a boost to sales, as margins have compressed. The strong performance of the shares makes shares relatively expensive for now, as I think that ambitious 2019 targets are not achievable.'
p7
aS"Bio-Techne Corporation Acquires Access to B-MoGen Biotechnologies' Gene ... PR Newswire  - May 4, 2016 MINNEAPOLIS, May 4, 2016 /PRNewswire/ -- Bio-Techne Corporation  and B-MoGen Biotechnologies, Inc. announced today that Bio-Techne has made a seed investment in B-MoGen and the parties have entered into collaboration&nbsp;..."
p8
aS'Bio-Techne Congratulates Astute Medical on Clinical Trial Results PR Newswire  - Jan 24, 2017 Bio-Techne Corporation  is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities.'
p9
aS"Bio-Techne  Q2 2017 Results - Earnings Call Transcript Seeking Alpha - Feb 7, 2017 Tables reconciling these measures to the most comparable GAAP measures are available in the company's press release issued earlier this morning on the Bio-Techne Corporation website at www.bio-techne.com. With that, I'll turn the call over to Chuck.BIO-TECHNE Corp  Releases Earnings Results, Misses Expectations By $-0 ... - Highland MirrorBio-Techne Corp  Issues Earnings Results - Sports Perspectives"
p10
a.